Tidetron Bioworks Technology Co., Ltd. ’s Post

For today’s #TidetronTech, let’s take a look at Tidetron Tao Automation R&D Platform. ⚙   It was officially launched in 2023, further integrating the synthetic biology DBTL cycle and significantly enhancing R&D efficiency. 🔍   In the upstream phase, this platform leverages multiple biological techniques such as strain and parts libraries, AI-assisted design, and gene editing to help construct the "cell factory". 🌟   In the midstream phase, it enhances efficiency through techniques such as directed evolution and microfluidics, highlighting the upgrades in efficient operation regarding product synthesis pathways, metabolic pathways, and fermentation regulation. ⭐   In the downstream phase, it can optimize and refine the production process, establishing a comprehensive system from laboratory-scale experimentation trials to pilot-scale amplification, ultimately leading to large-scale factory production.✨   As a platform-driven SynBio company, Tidetron is committed to fostering open collaborations to facilitate the translation of research achievements into industrial solutions. 💡 We can leverage innovative SynBio technologies to accelerate the technological advancement for our partners. Excited about reshaping traditional manufacturing with synthetic biology, let's head together towards a more sustainable "Biological Era." 🌍   #TidetronTao #Tidetron #SyntheticBiology #Innovation #TechnicalAdvantage #sustainabilityleadership

To view or add a comment, sign in

Explore topics